NEO

Q: What is the price of NeoGenomics (NEO) today?

The current price of NeoGenomics (NEO) is $ 7.91, representing a -20.18% gain over the past year. The stock began the year trading around $ 11.76 and is currently priced at $ 7.91. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does NeoGenomics (NEO) pay dividends?

NeoGenomics (NEO) did not pay dividends over the past year.

Q: Is NeoGenomics (NEO) a good investment?

NeoGenomics (NEO) is currently trading at $ 7.91 with a P/E ratio of -9.97%. This represents a -1,717% premium compared to its historical average P/E. Over the past year, the stock has gained -20.18 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -20.18%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

NeoGenomics Inc.

Price

$ 7.91

return (12m)

-20.18%

p/e

-9.97

p/bv

1.29

DIVIDEND YIELD

0.00%

NEO price

NEO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NEO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.64%

3 months

-38.25%

1 year

-20.18%

2 years

-44.22%

5 years

-84.70%

10 years

6.83%

Fundamentals NEO

review the fundamentals of NeoGenomics shares

P/E

-9.97

Sector: -2.29 Industry: -2.48

P/S (PSR)

1.48

Sector: 1.99 Industry: 2.74

P/BV

1.29

Sector: 2.18 Industry: 1.67

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-7.94%

Sector: -26.05% Industry: -22.47%

ROE

-12.91%

Sector: -29.81% Industry: 13.64%

ROIC

-3.49%

Sector: -416.93% Industry: -7.43%

NET MARGIN

-14.85%

Sector: -28.23% Industry: -34.76%

GROSS MARGIN

43.21%

Sector: 44.66% Industry: 48.45%

OPERATING MARGIN

-12.12%

Sector: -23.34% Industry: -5.22%

EV/EBITDA

-27.84

Sector: -0.62 Industry: 4.76

EV/EBIT

-10.11

Sector: -1.80 Industry: -1.09

PRICE-TO-ASSETS

0.79

Sector: 1.17 Industry: 1.57

BVPS

6.48

Sector: 3.79 Industry: 3.56

EPS

-0.84

Sector: -0.90 Industry: -0.69

EQUITY-TO-ASSETS RATIO

0.62

Sector: 0.43 Industry: 0.66

LIABILITIES / ASSETS

0.38

Sector: 0.46 Industry: 0.25

CAGR REVENUE 5 YEARS

8.47%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

66.87%

Sector: - Industry: -

Fundamentals NEO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	32.87	0.00	0.00%	0.00%	$ 95.25 B	14.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NEO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/18/2020	12/30/2020	0,40000000

ABOUT NeoGenomics

NeoGenomics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

1996

Time since IPO - 30 years

1.700

Employees

NeoGenomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.08 Billion, with shareholders equity totaling $836.56 Millions.

The company employs approximately 1.700 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, NeoGenomics Inc. reported $727.33 Millions in revenue, generating net income of $-108.02 Millions.

Key financial metrics include a P/E ratio of -9.97, a price-to-book (P/B) ratio of 1.29, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEO.

Market cap

$ 1.08 Billion

Net worth

$ 836.56 Millions

$ 836,560,000.00

Assets

$ 1.36 Billion

$ 1,359,830,000.00

Total Shares Outstanding

129.00 Millions

129,000,000

Average Daily Trading Volume

$ 1.95 Million

$ 1,952,832.00

Sector

Health

Industry

Health Establishments

NEO

NEO revenue and profits

Financial Results NEO

DRAG THE FRAME TO SEE MORE DATA

NEO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 78.86 25,27% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 279.72 --14,91% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 41.09 --33,27% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 214.95 --18,48% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 474.03 39,79% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 917.65 4,50% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 147.48 35,26% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25